Natco Pharma Ltd. - Research Center
524816 NATCOPHARM Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
964.80 |
625.30 |
930.50 |
1,048.30 |
781.20 |
Operating profit |
452.70 |
238.30 |
442.30 |
503.70 |
327.70 |
Interest |
4.50 |
3.80 |
3.00 |
3.20 |
1.20 |
Gross profit |
484.10 |
264.00 |
464.00 |
515.10 |
344.00 |
EPS (Rs) |
19.50 |
10.73 |
20.12 |
22.64 |
13.92 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
35.90 |
29.50 |
24.70 |
14.60 |
17.50 |
Stock adjustment |
-29.70 |
7.40 |
7.50 |
32.00 |
53.40 |
Raw material |
127.60 |
92.20 |
166.60 |
136.10 |
146.30 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
125.00 |
103.90 |
106.80 |
119.20 |
97.30 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
289.20 |
183.50 |
207.30 |
257.30 |
156.50 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
51.60 |
40.40 |
40.00 |
39.90 |
37.60 |
Taxation |
83.40 |
31.60 |
63.80 |
69.90 |
52.30 |
Net profit / loss |
349.10 |
192.00 |
360.20 |
405.30 |
254.10 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
35.80 |
35.80 |
35.80 |
35.80 |
36.50 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
46.92 |
38.11 |
47.53 |
48.05 |
41.95 |
GPM (%) |
48.38 |
40.32 |
48.58 |
48.46 |
43.07 |
NPM (%) |
34.89 |
29.32 |
37.71 |
38.13 |
31.81 |